Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Gisselbrecht

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Hematology Reports|May 16, 2012
Current approaches to the treatment of non-Hodgkin's lymphomaChristian Gisselbrecht
Blood|February 6, 2010
Molecular signatures in T-cell lymphomaChristian Gisselbrecht
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2014
Futility of relapsed diffuse large B cell lymphoma transplantation?Christian Gisselbrecht
Blood|November 13, 2012
TP53 mutations and rituximab-CHOPChristian Gisselbrecht
Leukemia & Lymphoma|February 2, 2011
A revival: radioimmunotherapy in mucosa associated lymphoid tissue lymphomaChristian Gisselbrecht
British Journal of Haematology|October 28, 2008
Use of rituximab in diffuse large B-cell lymphoma in the salvage settingChristian Gisselbrecht
Oncology (Williston Park, N.Y.)|September 6, 2014
Is Dose-Dense Therapy Effective Against DLBCL in the Era of Rituximab?Christian Gisselbrecht
The Lancet. Haematology|October 7, 2018
An unmet need for long-term follow-up in Hodgkin's lymphoma?Christian Gisselbrecht
Blood|July 27, 2013
Ofatumumab in diffuse large B cell lymphoma?Christian Gisselbrecht
Hematology. American Society of Hematology. Education Program|December 13, 2012
Is there any role for transplantation in the rituximab era for diffuse large B-cell lymphoma?Christian Gisselbrecht
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Hematology Reports|May 16, 2012
Current approaches to the treatment of non-Hodgkin's lymphomaChristian Gisselbrecht
Blood|February 6, 2010
Molecular signatures in T-cell lymphomaChristian Gisselbrecht
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2014
Futility of relapsed diffuse large B cell lymphoma transplantation?Christian Gisselbrecht
Blood|November 13, 2012
TP53 mutations and rituximab-CHOPChristian Gisselbrecht
Leukemia & Lymphoma|February 2, 2011
A revival: radioimmunotherapy in mucosa associated lymphoid tissue lymphomaChristian Gisselbrecht
British Journal of Haematology|October 28, 2008
Use of rituximab in diffuse large B-cell lymphoma in the salvage settingChristian Gisselbrecht
Oncology (Williston Park, N.Y.)|September 6, 2014
Is Dose-Dense Therapy Effective Against DLBCL in the Era of Rituximab?Christian Gisselbrecht
The Lancet. Haematology|October 7, 2018
An unmet need for long-term follow-up in Hodgkin's lymphoma?Christian Gisselbrecht
Blood|July 27, 2013
Ofatumumab in diffuse large B cell lymphoma?Christian Gisselbrecht
Hematology. American Society of Hematology. Education Program|December 13, 2012
Is there any role for transplantation in the rituximab era for diffuse large B-cell lymphoma?Christian Gisselbrecht
Pageof 15